Whitefort Capital Management, LP

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), Whitefort Capital Management, LP reported 17 stock positions worth $316.6 million. Its top holding was Arbutus Biopharma (ABUS) at 21.2% of the portfolio, followed by Roivant Sciences (ROIV, 12.4%) and Joyy Inc.-ADR (JOYY, 9.7%). Compared with Q4 2025, it opened 3 new positions, sold out of 1, added to 6 and reduced 3. The biggest buy was a new position in Pubmatic Class A (PUBM) and the biggest sale Roivant Sciences (ROIV, shares −33%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001884931
Portfolio Value
$316.6M (Q1 2026)
SEC Filing
0001013594-26-000606 ↗ filed May 15, 2026

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q1 2024: $153.2M Q1 2024 Q2 2024: $143.4M Q2 2024 Q3 2024: $201.5M Q3 2024 Q4 2024: $191.5M Q4 2024 Q1 2025: $185.2M Q1 2025 Q2 2025: $239.0M Q2 2025 Q3 2025: $287.4M Q3 2025 Q4 2025: $317.7M Q4 2025 Q1 2026: $316.6M $316.6M Q1 2026 Q2 2026: $391.6M Q2 2026

Holdings 17 stocks · $316.6M
ABUS Arbutus Biopharma Corp. 21.22% 14,930,885 $67.2M Add +11.9%
ROIV Roivant Sciences Ltd. 12.41% 1,419,000 $39.3M Reduce -33.1%
JOYY Joyy Inc.-ADR 9.68% 524,944 $30.7M Add +29.6%
SOC Sable Offshore Corp. 8.06% 1,544,793 $25.5M Reduce -19.1%
GNW Genworth Financial Inc. 8.03% 3,130,301 $25.4M Add +23.2%
BALY Bally's Corp. 7.33% 2,408,063 $23.2M Add +25.3%
OABI Omniab Inc. 7.05% 14,223,658 $22.3M No change
TDAY USA Today Co. Inc. 6.96% 3,124,833 $22.0M Reduce -34.6%
CDZI Cadiz Inc. 6.18% 3,986,822 $19.6M No change
SGRY Surgery Partners Inc. 3.43% 911,136 $10.9M Add +51.9%
QURE Uniqure NV 3.40% 657,611 $10.8M Add +43.3%
PUBM Pubmatic Inc. Class A 1.78% 690,000 $5.6M New
OPK Opko Health Inc. 1.53% 4,253,340 $4.8M No change
VATE Innovate Corp. 1.33% 743,000 $4.2M No change
TEAD Teads Holding Co. 0.75% 3,610,103 $2.4M New
KG Kestrel Group 0.55% 160,916 $1.7M No change
NN Nextnav Inc. 0.31% 60,655 $972K New

Options reported separately and not counted above: GLD calls ($10.5M).

Other holdings (2): bonds, preferreds, convertibles and warrants · $11.9M (not counted above)
SecurityClassShares / PrincipalValueChange
OPKO HEALTH INC (OPK 3.75 01/15/29) NOTE 3.750% 1/1 · principal 9,350,000$11.6MNo change
NNAVW Nextnav Inc. *W EXP 99/99/999 47,264$299KNo change

Total filed on the 13F, all lines: $328.6M.

Portfolio Sells Q4 2025 → Q1 2026
ROIV Roivant Sciences Ltd. Reduce -33.1% 12.41% −2.07
LQDA Liquidia Corp. Sold out 0.00% −1.72
TDAY USA Today Co. Inc. Reduce -34.6% 6.96% −0.78
SOC Sable Offshore Corp. Reduce -19.1% 8.06% +2.63

Portfolio Buys Q4 2025 → Q1 2026
PUBM Pubmatic Inc. Class A New 1.78% +1.78
JOYY Joyy Inc.-ADR Add +29.6% 9.68% +1.42
ABUS Arbutus Biopharma Corp. Add +11.9% 21.22% +1.01
GNW Genworth Financial Inc. Add +23.2% 8.03% +0.81
TEAD Teads Holding Co. New 0.75% +0.75
SGRY Surgery Partners Inc. Add +51.9% 3.43% +0.51
NN Nextnav Inc. New 0.31% +0.31
QURE Uniqure NV Add +43.3% 3.40% −0.06
BALY Bally's Corp. Add +25.3% 7.33% −2.66

Options Activity Q4 2025 → Q1 2026
MRNA Moderna Inc. put Sold out 1,000,000 $29.5Mbefore exit
LQDA Liquidia Corp. call Sold out 594,700 $20.5Mbefore exit
GLD SPDR Gold Shares call Reduce -9.6% 24,400 $10.5M

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 18$391.6MABUS, ROIV, JOYY, BALY, GNW
Q1 2026 17$316.6MABUS, ROIV, JOYY, SOC, GNW
Q4 2025 15$317.7MABUS, ROIV, BALY, OABI, JOYY
Q3 2025 14$287.4MABUS, ROIV, GNW, JOYY, OABI
Q2 2025Amended 14$239.0MJOYY, ROIV, ABUS, GNW, OABI
Q1 2025 11$185.2MABUS, ROIV, JOYY, GNW, LQDA
Q4 2024 13$191.5MABUS, ROIV, LQDA, GNW, CDZI
Q3 2024 13$201.5MABUS, EDR, ROIV, JOYY, GNW
Q2 2024 16$143.4MABUS, ROIV, NN, GNW, GSL
Q1 2024 13$153.2MGSL, ABUS, ROIV, LSXMK, GNW